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ABSTRACT
Liver enlargement in rats resulting from oral administration of pyrethrum has been observed in various laboratories.
This study was undertaken to investigate the nature of this
enlargem en t as well as resulting changes in hepatic drug metabolism.

Oral administration of pyrethrum at 200 mg/kg for 13

or 23 days resulted in decreases in

h~patic

DNA

concentrations~

While total lipid concentrations were increased significantly,
tha increases did not account for the enlargement.

Protein

concentrations of whole liver homogenates, 9,000 x g supernatants and the 105,000 x g pellet were not different from
controls,

No signific a nt c han ges occurred in hepatic water

concentrations.

Accompanying histologica l observations of

the enlarged livers indicated cellular

hypertrophy~

Significant decreases in hexobarbital induced hypnosis
without

conco~itant

changes ir1 ba rbital induced hypnosis

suggested a pyrethrum ca used alteration in hepatic drug metabolism.

The activities of hepatic microsomal enzymes responsible

for EPN detoxification, p-nitroanisole

de~ethylation

and hexo-

barbital oxidation were incre ased to 150, 173 and 241 percent
of control, respectively.

No significant increases were noted

in the demethylation of aminopyrina or oxidation of L-tryptophan.
Incre ases in liver weight, the detoxification of EPN and d erneth ylation of

p-nitroa n is~le

were

i-

fou~d

to be

~ose

related.

IncLeased enzyme activities were observed at the lowest dose
used of 85 mg/kg/d3y for 15 days.

At a dose of 500 Tig/kg/day,

liver w9ights and enzyme activities were increased continually
during a 17 day period of treat ment but returned to control
leval within 7 days after cessation of treatment.

NADPH-

cytochrome c reducta s e and P-450 concentrations were also
increased.

These data show that pyrethrum caus e s significant

liver enlarg em ent with accompanying increases in microsomal
drug metabolizing activity.

They suggest a re-evaluation

of the use of pyrethrum as a non-inducing insecticide.
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I.

INTRODUCTION

In recent years increa3ing interest has developed in tha
toxicity of the various classes of pesticides.

The organo-

chlorine insecti~ides, and DDT in particular, are of growing
ecologic al concern becauss of their widespread use and extreme
persistence and the difficulty in evaluating the harmful effects
of th ese low residues upon such parameters as the fertility of
animals and fragility of bird eggs (O'Brien, 1967).

The unre-

stricted use of these halogenated hydrocarbons in libor atory
animal quarters has also been of concern (Fouts, 1963).

Since

enzyme induction can seriously affect the results of tests
meant to evaluate the metabolism or the acute or chronic toxicity
of drugs, care should be taken to exclud3 such insecticides
from quarters of animals used in such studies (Conney, 1967).
Another

type ~

of insecticide, the organophosphates, fer example

parathion and malathion, are inhibitors of

cholineste~ase.

Although they are rapidly hydrolyzed and thus are not persistent,
the acute mammalian toxicity is high.
Pyrethrum, an extract of the pyrethrum flo wer Chrysant hemum
cinararia efolium , contains four esters of complex alcohols and
acids called pyrethrin I and II and cinerin I and II (S hepard ,
1939).

As an insec t icid e , it has found wide use in agriculture,

forestry, the home, and laboratory animal quarters because of
its favorable properties.

It demonstrates a low mammalian

7

toxicity (Negherbon 1 1959), but at the same time has a high
knockdown and kill rate on many classes of insects (Metcalf,
195 5 ).

Instability towards mild acid or alkali, and direct

sunlight limits its persistence in the environment (Chen and
Casid a , 1969).

It has been generally assumed that pyrethrum

is safe for use .i n situations requiring a

non-~nducing

insscti-

ci de, such as in quarters housing animals undergoing ph3rma cological t esting (Fouts, 1963; Conn ey , 1967).

Although no

data was presented , the use of pyrethrum and piperonyl butoxide
was reco mmen ded since there was no detected effect of these
materials on hexobarbital induced narcosis or microsomal drug
metabolizing enzyme activity .
In examining the combin3d effe cts

or

DDT , pyrethr um ,

and pi pe ro ny l butoxide , Kimbrough et al (1968) found that

--

pyrethr um , especially synergized pyrethrum, produced liver
enlargement and cellular changes including margination and
cyto plasmic inclusions .

These changes were proportional to

dosa ge and similar in ch arac ter to changes caus Gd by DDT.
However, these studies were concerned only with morph ologic al
chang es and did not include biochemical observations.

Resu!ts

from our laboratory of 90 day toxicit y studies cond u cted in
rats

e~ploying

25 percent of the oral LD50 also showed that

pyrethrum, pipgronyl butoxide , tropital and sulfoxide, alone
and in co mbination , caused liver enlargement ( Bond and Defeo,
1967-1969).
Liv er enlargement which may be indicative of abnormal
structur al changes or other pathology often accompanies the

8

stimulation or inhibition of drug biotransformation (Conney,
1967).

Since the rate of hepatic drug biotransformation

influences the resultant pharmacodynamic activity of a compound
(Conney, 1967), it seemed important to examine the nature of
the liver enlargement caused by pyrethrum, as well as possible
a 1 t e r a t i on s i n t.h e h e p at i c b i o tr an s form a t i o n o f, d r u gs •
Initial investigations were designed to explorn the physical
causes of the enlargement, i.e.,

whethe~

deposition, hyperplasia, or hypertrophy.
examined the . nature and extent of

due to edema, fat
Further studies

alte~ations

in hepatic bio-

transformation of drugs while additional work suggested a
possible mechanism for such alterations.

9

II.
A.

Pharmacology

REVIEW OF THE LITERATURE

E.f.

the

P._yrethrin~_.

Early work dealing with the toxicity of pyrethrum centered
on its effects on mammalso

The reported results varied with

route of administration, species and vehicle used (Shimkin and
Anderson, 1936; Ambro3e and
Bond and DeFeo, 1967-1969) •.
an

86~2

g/kg.

Rob~ins,

1951; Negherbon, 1959;

The acute oral LD50 in rats for

percent solution of pyrethrins was greater than 2.6
No mortality was observed in rats administered 1.6 g/kg

subcutaneously (Ambrose and Robbins, 1951).

Negherbon (1959)

reported an oral LD50 for rats of 820 mg/kg and 1500 mg/kg
for guinea pigs.

A dose of 6-8 mg/kg was toxic to do~s when

administered intravenously, suggesting that pyrethrum possessed
a potent intrinsic toxicity.

The acute oral LD50 in rats for

a commercial solution of pyrethrum (20 percent pyrethrins, 80
percent petroleum distillates) was 7200 mg/kg or the equivalent
of 1440 mg/kg of pyrethrum alone (Bond and DeFeo, 1967-1969)0
The acute oral LOSO in rats for

pyreth~in

I dissolved in

dimethylsulfo x ida was reported to be 260-420 mg/kg while that
of pyrethrin II was greater than 600 Tig/kg.
Administered orally in 6 doses over 12-54 hour periods,
rats survived 450-2000 mg/kg of pyrethrin I and greater than
2900 mg/kg of pyrethrin II (Cassida

tl

tl

~'

1971).

Carpenter

al . ( 1950) found tha-: rats were able to ingest over a

2L~

hour

10
period a quantity which was lethal if administered in a single
dose and were able to maintain the intake for long periods
without apparent injury.

Bond and Dereo (1967-1969) noted

that rats were able to tolerate a dcse of

i'

the oral LD50 for

periods of 90 days without significant increases in mortality
over that of controls.
The chronic dermal toxicity of pyrethrum (20 percent
pyrethrum, 80 percent petroleum distillates) to rabbits and
the chronic vapor toxicity to mice, rats, guinea pigs and
rabbits, as well as the associated histopathology of these
animals is reported by the Office of the Surgeon General (1951,
1952).

Slight to mild skin irritation was observed in rabbits

upon application of 1 ml/kg/day for approximately 30 days,
with further applications progressing in severity.

However,

these same effects were produced by the solvent which was tested
alone, suggesting that the effects were not due to pyrethrum
but to the

solve~t.

Continuation of exposure to saturated

vapors of pyrethrum extract for 5 weeks, 8 hours daily, 5
days per week caused a 40 percent mortality in mice; preening,
eye irritation and unthrifty appearance in rats;

unthrifty

appearance in guinea pigs; 3nd no apparent effects in rabbits.
On a comparable basis, vapors from the solvent appeared to be
more toxic than the extract and accounted for the toxicity of
extract_

The histopathology of the tissues from these animals

showed primarily vascular congestion which was more pronounced
ih the lungs and kidneys than other tissues.

These effects

11

were more severe in solvent treated anim a ls.
Early studies by Feinberg (1934), Garratt and Bigger(1923),
and IY1 c Co rd tl ~

( 1 9 2 1 ) s h ow e d

t hat s k i n con ta ct a n d i n ha 1 a ti on

may cause allerg3nic attacks in sensitive people.

Patients

sensitive to ragweed developed allergic reactions to extracts
of ground

pyret~rum

flowers; severe dermatitis and anaphylactoid

reactions were also reported,

IYlore recent studies using re-

fined pyrethrum suggested th a t there was no potential allergy
to insecticides containing pyrethrins, as opposed to the
unrefined material (Zucker, 1965).
Structurally related new synthetic derivatives of pyrethrum .
demonstrated toxicities similar to that of pyrethrum:
(Ambrose and Robbins, 1951; Carpenter

tl

~'

195Da, 1950b), barthrin (Ambrose, 1963; IYlasri
1964b), dimethrin (Ambrose, 1964; Masri
and others (Chikamoto, 1964).

allethrin

1950; Starr

tl

a~,

tl ai,

1964a,

tl al, 1964a, 1964b)

Increased liver and kidney

weights were noted in animals chronically fed barthrin or
dimethrin (Ambrose, 1963, 1964) together with the reversible
appearance of hepatic cytoplasmic inclusions (Masri

tl

~'

1964b).

many reviewers of this subject conclude that the effective
and rapid knockdown action of pyrethrum in insects results
from an initial impairment of neuromotor systems (Shepard,
1951; Roeder, 1953; Metcalf, 1955; Negherbon, 1959; O'Brien,
1967).

Earlier studies with arthr opod nerves showed that

direct application of pyrethrum caused initial e xcit a tion followed by block (Ellis ot
and Gordon, 1947).

~'

19 4 2; L.0 1JJe ns t e i n , 1942; Welch

Allethrin a n d other synt hetics act in a
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similar mann e r c a us ing repetitive disc harga, negative a fter
pot e ntial and conduction block and ha ve be e n t e st e d in cockroach giant a xon fi bers (Nar a has hi, 19 62a, 196~b) 1 squid
giant axons (Narahashi and Andersor1, 19 67) and crayfish giant
axons (Berteau~~' 1968; Ca mougis et~' 1971) with microelectrode

techn~ques9

Pyrsthrum in low co n c e ntrations will

block crustac e an syn ap ses (Schalle k and Wier s ma , 194 8 ).
However, the ex a ct part of the syst e m involved , central versus
peripheral, i s a matter of controversy (Ke a rns, 1956).

Pyre-

thrum does act on the sensory nerve . endings causing temporary
paralysis, and further poisoning effects may occur from localized action along the axon.

Centrally , pyrethrum stimulates

repetitive discharge of nerve cells and fibers and later
results in paralysis.
In contrast to the relatively numerous st udies with
arthropods, little information exists on the direct action of
pyrethrum on vertebrate nerve.

The gro s s syndrome in mammals

includes excitation, tremor and convulsion sugge s ting actions
on the nervous system (Negherbon, 1959; Hayes, 1965).

Camougis

et al (1971) made a comparative study of the neuropharmacoloical
basis of action of pyrethrins in arthropods and vertebrates.
The results from isolated nreve preparations showed that spontaneously active ganglia , or the electrically stimulated
peripheral nerve of the cr a yfish, wa s pa rtic u larly sensitive
to the blocking effects of pyr e thr um, but ins en sitive tu lidoca~ne.

In contrast: both the fro g ner ve a n d r a t nerve we re

resistant to a cute block by pyrethrum but se ns itiv e to lidocaine.
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These apparent differences could not be attributed to the
vertebrate nerve sheath, as shown in de sheathe d nerve preparations, and suggested a possible basic difference in the mechanisms of action.

In whole animal studies,

do ses of pyre-

~ow

thrum, 1-10 ug/kg, disrupted and blocked electrical activity
of the heart in .crayfish Luhile doses c:.s high as. 1000 mg/kg
failed to stop the frog heart.
The earliest work on the metabolism of pyrethrum in insects
led to the sugg es tion and virtual assumption that hydrolysis
of the ester group was a major metabolic route (Bridges, 1957;
Chamberlain, 1950; Chang and Kearns, 1964; O'Brien, 1967;
Wi n t er i n g ham At ~ , 1 9 5 5 ; and Ze id ~t .51J:. , 1 9 5 3 ) •

The s e s tu d i e s

had limited success because the radiolabeled compounds used
had either low specific activity, were mixtures of isomers -.m
were otherwise impure.
Sever a l

c14 -labeled

pyrethroids, stereochemical ly pure

isomers of high activity, were recently synthesized (Nishizwa
and Casida, 1965; Yamamoto and Casida, 1968).

With these com-

pounds it was possible to show that allethrin, pyrethrin I,
phthalthrin and dimethrin
flies and in
system.

~}tro,

~ere

metabolized in living ho use -

in the housefly mixed-function oxidase

Attack occurred at the trans-(major site) and cis-

(minor site) methyl groups of the isobutenyl side chain in the
acid, forming in sucession, the corresponding hydroxymethyl,
aldehyde, and 2cid compounds.

.

No hydrolysis or attack on the

alcoholic part of the ester was det ected (Ya mam oto and Casida,
1966; Yama mo to~~' 1969) 0
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While there is some information about the metabolism of
pyrethrin I and r e lat e d co mpo u nds in houseflies, relatively
little is known about its fat e in mam ma ls.
work

(Casida~

The most recent

al, 1971) indica ted that in rats each of the

principal metabolites of pyrethrin I and II retained the cyclepropane e s ter lLnkage and

~as

formed by modific a tion of both

the acid and the alcohol moieties.

The sites of attack were

the trans-methyl group on the side chain of the acid and the
double bond of the alcohol side chain.

However, with allethrin,

there was also hydroxylation at the methylene group of the
allyl side chain and hydrolysis of the central ester

linkage~

W!1en barthrin and dim e thrin was fed to rabbi ts, chrysanthemumic
acid and the corresp onding alcohols or acids were recovsred
from the urine (IYlasri ~ ~' 1964), though the major part of
the metabolite was not

identified~
I

B.

Live£ Enlarg em ent
The physiological significance of enhanced liver growth

and function in animals treated with various drugs has not
yet been determined and it is not clRa r whet her these ~ffects
are harmful or beneficial (Conney, 1967).

While erlargement

of the liver is generally regarded as a pathological phenomenon
(Kunz, 1966), the concern lies with the increase in relative
liver weight in the absence of histopatholoical effects indicative of liver dam a ge (Golber g , 1964).
Organ weight is related to body weight according to the
principle of allrn ,1 etry, so th a t a log-log pl o t of body wE i ght
against liver weight yields a str a ight lin e { Addis and Gray,

15
1950)~

Published data for the rat varies somewhat in this

respect (Zumoff and Pachter, 1964; Setnik ar and Magistretti,
1965), and attention has been called to the error introduced
by comparisons of organ weights of rats when the body weights
are consistently different (Setnikar and Magistretti, 19 65 ).
Ho1.1Jever, data f o.r some strains of rats in com mon use t evealed
satisfactory liver to body weight correlations at 13 and 25
months (Sherm an ,

1963)~

Phe ~ obarbital

increased drug-metabolizing activity in

hepatic microsomes and exerted an anabolic effect on the liver
which resulted in a 20-40 percent
tein per g liver. (Conney .§.l

tl'

inc ~ease

in microso ma l pro-

1960; Conney and Gilman, 1963) ..

In contrast, 3-methylcholanthrene, a polrcyclic hydrocarbon 1
stimulated liver growth and the synthes;s of total liver
protein with little or no increase in the concentration of
microsomal protein (Conney and Gilman, 1963; Arcos .§.l al,
1961).

The~e

hydr~carbons

studies suggested that the ability of polycyclic
to stimulate liver growth was .related to their

--

ability to induce
microsomal
enzyme formation (Arcos et al,
.
.
1961) .

Some drugs, such as chloroform, halothane and penthrane,

caused liver enlargement without enhanced liver microsomal
activity and the enlargement was showr. biochemically not to
be due to · fat or ede ma (Kunz, 1964; Kunz .§.l

tl,

1966).

In a

structure activity relationship study of p heno l derivatives,
no corr e lation was found between the enhance me nt of liver
growth and stimulation of aminopyrine demethylat ion or hexobarbital oxidation (Golber g , 1964; Gilbert et

tl'

1969).
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In view of the diversified effects of various drugs on the
liver , it was of interest to determinG what biochemic a l effects
would be associated with liver enlargement due to pyrethrum .
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III.
A.

EXPERIMENTAL

Animals
Sprag ue -Dawley rando m bred, male albino rats obtained

from Charles River Breeding Laboratories, Wilmington, Ma ss .,
weighing 100-300 g were used.

The animals were housed in

quarters maintained at 21-23°C with room lights on alte~nating
12 hour light-dark cycles.
were allowed ad libitum.

Commercial laboratory chow and water
Animals were

u~ed

5 days following receipt from the supplier.

no earlier than
Pyrethrum and

corn oil were administered by oral intubation, while all other
drugs were administered intraperitoneally.
8.-

Materials
Analytical grade chemicals or equivalent were used throu9h-

out this study.

Cofactors (NADP, NADPH and glucose-6-phosphate)

and s u b s tr at es ( c y t o ch r om e c , L- tr y p t op ha n a.n d p - ch 1 or om et h y 1a nil in e were obtained from Calbiochem., Los Angles, Calif. or
from Sigma Chemicals, St. Louis, Mo.

Crystall in e bovine serum

albumin was obtained from Armour Laboratories, Kankakee, Ill ••
Drugs used were obtained from their respective

man u fa~turers.

Pyrethrum, 20 percent mixture of pyrethrins I and II and
cinerin I and II in corn oil, was obtained from the Mcla ug hlin
Gormley King Co., Inc., Minneepolis, Minn •• Mazola corn oil was
used as the control vehicle.

c,

Me asurement

Ef

Dr ug -Induced Narcosis

Duration of hexobarbit a l induced narcosis was taken as
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the interval between injection of the drug and the return of
righting reflex, the endpoint of which was determined according
to Wenzel and Lal (1959) using two rightingswithin 30 sec.
Barbital induced narcosis was measured as the time of loss and
the return of righting ref lex.

The interval between injection

of the drug and loss of righting reflex was designated as onset
of narcosis.
D.

Preparation

E.f

Rat Liver

~ernatant

Fractions

Rats were guillotined 24 hours subsequent to th e last
administered dose of pyrethrum or corn oil.

Livers were

perfused i.n situ with ice-cold 0.15 M KCl and were homogenized
in 2-3 volumes of ice-cold 0.1 M phosphate buffer (pH 7.4) at
1000 RPM for 1 min in · a coaxial glass homogenizer with teflon
pestle.

The 9,000 x g supernatant fraction

~as

obtained by

0

centrifugation at 0 C for 30 min (10,000 rpm in a model 8-60
International Preparative Ultracentifuge (IEC) #874 rotor).
0

Portions of this fraction were then stored at -20 C until assayed.
The 105,000 x g pellet was obtained by centrifuging
0

aliquots of the 9,000 x g supernatant at 0 C for 2 hours in an
IEC preparative ultracentrifuge, #A-170 rotor, 37,000 rpm.
This pellet was dispersed in 0.1 M phosphate buffer (pH 7.4)
and stored at -20°c until assayed.

In instances when only the

protein concentration of this pellet was de t erw. ined, the pellet
was digested in 0.5 M NaOH and assayed.
E.

Analytical Procedures

.

All incub ations were carr ied out in
shaker under ai.r.

2

Dubnoff metabolic

All absorbance re a dings were determined in
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a Beckman DB-G spectrophctometer.
1.

Determin ation of Hepatic

~ater

Concentrations

Four ml aliquots of whole liver homog enate equal to 1.0 g
of liver were placed in 50 ml tared beakers and frozen in
liquid

nitrogen~

The samples were lyophilized for 40 hours

at 0.5 mm pressure with no external heat in a Virtis LyophilizDr,
Research Equipment, Gardner, N.Y ••
as the percent loss in
2.

Water content was determined

~eight.

Detern:2-nation of Hepatic Total Lipids

The method of isolation of total .lipids was essentially
that of Folch

~ ~l

(1957) with modifications by Sperry and

Brand (1955) and further modified by using lyophilized tissue.
Lyophilized liver tissue, 1 g equivalent of whole liver, was
powdered with e glass stirring rold and mixed for 20 min with
20 ml of a 2:1 chloroform-methanol mixture.

The extract was

suction filtered into 50 ml centrifuge tubes and mixed witt1
solution~ to remove
2
The tubes were capped and centrifuged. The

4.0 ml of a 0.04 percent aquEous CaC1
interphase fluff.

upper phase was aspirated carefully to avoid losing any of the
lower phase •.
The inside wall of the tube was rinsed with 3.0 ml of an
upper phase solvent mixture obtained from the separation of
an 8:4:3 mixture of chloroform, methanol and

~ater.

The upper

layer was then aspirated and the procedure repeated twice.
The remaining extract was diluted with methanol to form one
phase and

~ransferred

to tared 50 ml Erlenmeyer flasksc

solution was evaporated to dryne ss at 35-40

0

The

in a stream of
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nitrog en to prevent oxidation of lipids.
dryed overnight in a vacuum
3.

desicat~

The res id ue was

containing dri-rite.

Determination of Hepatic DNA

The extraction of DNA was carried out according to the
procedure of Schneider (1945), while the method of

~easurement

was that of Burton (1956).
One ml of whole liver homogenate was mixed with 2r5 ml
of ice-cold 10 percent trichloroacetic acid (TCA)
fug ed.

1

and centri-

The supernitar1t was decanted and discarded.

The residue

was suspended in 2.5 ml of TCA and centrifuged and the supernatant decanted and discarded..

This procedure removed acid

solu ble phosphorous co mpounds.
The tissue residue was suspended in 1.0 ml of wEter, and
4.0 ml of 95 perc ent ethanol added.

The mixture was centri-

fuged and the supernatant was decanted and discarded.

The

resi due was resuspended in 5.D ml of ethanol followed by centrifugatio~

and disposal of the supernatant.

removed residual

TCA~

This procedure

The residu e was then boiled 3 times for

3 min each in 5.0 ml of a 3:1 mixture of ethanol and ethyl
ether, followed by centrifuging and discarding the supernatant
to remove phospholipids.
The re sidue , resuspended in 1.2 ml of water, and mixed
with 1.3 ml of cold TCA, was centrifuged and the supernatant
discarded.
The r esidue was suspended in 5.0 ml of 5 percent TCA,
heated far· 15 min at 9D 0 c, cooled and centrif u gs d .
natant was decanted and saved.

The residue was

The super~

~ <.,J s pended

in

21
2,5 ml of 5 percent TCA, centrifuged and the supernatant
decanted~

The TCA extracts were combined to form a nucleic

acid extract (7.5 ml).
In the development of a chromophore, equal volumes of
TCA extract and 1o0 N perchloric acid were mixed.

To 2 ml of

this mixture was added 2.0 ml of diphenylamine reagent containing acetaldehyde.

This reagent was prepared by dissolving

1.5 g of diphenylamine in 100 ml of glacial acetic acid and
adding 1.5 ml of concentrated sulfuric acid.

On the day of

use, D.1 ml of aqueous acetaldehyde (16 mg/ml) was added for
each 20 ml of reagent required.

A reagent blank was prepared

containing an equal valuma of 5 percent TCA and 1.0 N perchloric
acid.
The above mixtures were incubated after capping .at 30°C
for 16-20 hours and read at 6QO nanometers verses the reagent
blank.
4.

Determination of Hexobarbital Oxid3tion

The oxidation of hexobarbital was estimated by measuring
the disappearance of substrate using the method of Cooper and
Brodie (1955).

One ml of 9,000 x g supernatant was added to

an incubation mixture containing 2.12 umoles of hexobarbital,
25 umoles of glucose-6-phosphate, 12.0 umoles of magnesium
sulfate, 100.0 umoles of nicotinamide, D.65 umoles of NADP and
sufficient 0.1 M phosphate buffer, pH 7.4, to make a final
volume of 4.0
of

ml~

hexoba~bital

Two parallel flasks, one containing 100 ug

with boiled tissue and the other containing

tissue but not hexobarbital, wa re incub a t e d at 37°c for 30 min
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and carried through the procedure to serve a s bla,k .
The barbiturate was extracted and quantitatively me asured
accordi n g to a procedure described by

Brodie~~

(1953).

The above incubation mixtures were tran s ferred to 50

~l

centri-

fuge tubes containing 1 g of sodium chlorid e and 30 ml of
petroleum ether (technical grade, B.P. 37-47°c and purified by
washing with 1 N NaOH, 1 N HCl and 2 washings with water) containing 1.5 pe r cent isoamyl alcohol.
pH 5.5 was ad d ed.
and centrifuged.

Phosphate buffer, 1.5 ml,

The tubes were capped, shaken for 45 min
Twenty ml aliquots of the petroleum ether

layer were tiansfe r red to 50 ml centrifuge tu bes containing
10 ml of phosphate buffer, pH 11.0.

shaken for 10 min and centrifuged.
ated.

The tubes we re capped,
The upper phase was aspir-

The absorbance of the unmetabolized barbiturate remaini n g

in the buffer layer was determined at 24 5 nanometers versus
pH 11 buffer.

The

concen~ration

of the unmetabolized barbit-

urate in the sample extract was compared with a stand a rd solution
prepared by dissolving 10 mg of the barbiturate in sufficient
distilled water to make 100 ml.

A te n fold dilution was then

made with pH 11 buffer and the abso r bance of the resultant
solution (100 ug/ml) obtained.

Recovery of the barbiturate

added to the homogenate was 90-100 perc e nt.
5.

Determination of Serum Level of Hexobarbital

Rats were sacrificed by guillotine imm a diately upon 'return
of righting reflex and free flowing blood collec t ed in conical
.

centrifug e .tubes on ic e .

Serum was obtained by c entr ifugation

fo r 10 min in a clini ca l centrifug e .

The ex t r a ct i c

procedure
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of Brodie

et~

(1953) was performed as described in the

dstermination of hexobarbital oxidation except that 2 ml of
serum, and 4 ml of pH 11 buffer was used.
6.

Determination of Aminopyrine N-Demethylase

The N-demethylation of aminopyrine was estimated by
measuring the formation of formaldehyde according to the
method of McMahon and Easton (1962).
One ml of 9,000 x g supernatant was added to an incubation
mixture containing ·10

u~oles

of aminopyrine, 45 umoles semi-

carbazids, 15 umoles glucose-6-phosphate, 2 umoles NADP, 50
umoles magnesium chloride, 50 umoles nicotinamide and sufficient
0.1 M phosph3te buffer, pH 7.4, to make a total volume of 5.0
ml.

Parallel incubation flasks containing 1.32 umoles of

formaldehyde (standard) in place of substrate and distilled
water (blank) in place of substrate were carried through the
entire procedure.
min.

0

Incubation was carried aut at 37 C for 60

A second experiment was performed in which the incubation

period was altered.
The samples were
manner.

ae~ayed

for formaldehyde in the following

The flask contents were poured into 15

~l

centrifuge

tubes containing 4.0 ml of 10 percent zinc chloride solution
prepared with CO -frea water. After mixing, 2.0 ml of a sat2
urated solution of barium hydroxids was add~d and the samples
were again mixed.
5.0 ml

aliq~ots

The tubes were centrifuged for 10 min and

of clear supernatant were transferred to 15

ml centrifuge tubes containing 2.0 ml of double strength Nash
reagent (0.04 M acetylacetone in 0.4 M ammonium acetate-0.1 M
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acetic acid)o

The contents were mixed and the tubes heated
0

in a water bath at 60 C for 30 min.

Absorbance was determined

at 410 nanometers versus a tissue blank.

The amount of form-

aldehyde formed was determined by comparison with the absorbance of standards.
7,

Deterinin.ation .9i_ p-Chloro-N-methylaniline N-Dernethylation

Determination of p-chloro-N-methylaniline (PCMA) was
determined by assaying of p-chloroaniline formed according
to the procedure of Kupfer and Bruggeman (1966) as modified by
Fuller et~ (1969).

IncubatiJns were carried out at 37°c

for 30 min in media containing 3 umoles PCMA, 1 . 6 umoles NADP,
16 umoles glucose-6-phosphate, 30 umoles MgC1 , 20 umoles
2
nicotinamide, 120 umoles phosphate buffer , pH 7~4, and 9,000
x g rat liver supernatant containing 2-4 mg protein.

The

reaction was stopped by the addition of 3.0 ml p-dimethylaminobenzaldehyde (20 mg/ml in 1 N H so ).
Incubation flask
2 4
contents were mixed and centrifuged at 8,000 x g for 30 min.
Absorbances were read at 445 nanometers and were corrected for
abso_bance of blanks.

The amount cf p-chloroaniline formed

was determined by comparison with standard solutions of
p-chloroaniline .
8.

Determination of O-·Ethyl,0-(4-nitropheng)phenyl.Ehos-

phonothioate Detoxification and p-Nitroanisole

0-p~methylation

The detoxification of 0-ethyl, 0-(4-nitrophenyl)phenylphosphonothioate (EPN) and the

0-dem~thylation

of p-nitro-

anisole was estimated by measuring the formation of p-nitro phenol according to the.method of Neal and DuBois (1965), as
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suggested by Netter and Seidel ( 1965)q
To an incubation mixture containing 1.3 umoles NADP,
3.3 umoles glucosa-5-phosphate, 0.2 ml EPN-buffer and sufficient
water to make a

t~tal

volume of 0.8 ml was added D.1 or 0.2

ml of 9,000 x g suparnatant, diluted 1:1 with 1.15 percent KCl
contai ning 0.25 percent nicotinamide.

The EPN-buffer was

perpared by dissolving EPN, 2.0 mmoles in 1:4 ethanol, propylene
glycol and adding 0.5 ml of this solution to 5 ml of 0.1

m

pho sphate buffer , pH 7.8.
Incubation was carri ed out at 37°C for 60 min.

The reaction

was terminated by adding 2.5 ml cold acetone to the reaction
flask.

The flask

conten~s

were pcured into centrifuge tubes

and 0.2 ml glycine-NaOH buffer (0.5

m,

pH 9.5) was added.

The

tubes were centrifuged and the supernatant read at 410 nanometers versus blank to which tissue had been added at the
termination of incubation.

The amount of p-nitrophenol formed

was determined by comparison with the absorbance of blanks.
The

~pocedure

for measuring 0-demethylation of p-nitro-

anisole was the same as above except that p-nitroanisole, Oo9
mmoles was substituted for EPNo
9.

Estimation of Protein

Protein content

W3S

determined by the colorimetric pro-

cedure of Lowrey~ <3.l (19 51 ) with minor mJdifications. · ·An
aliquot of 0.4 ml of microsomal fraction of an aliq u o t of 0.2
ml of 9,000 x g supernatant was added to a 15 ml
cont aining 10 ml of 0.5 m NaOH .

t e ~t

tube

The tubes were he -e d in a

water bath at 60°c for a complete dissolutio n .

s · .,. - : rd
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solutions of crystallin bovine serum albumin and a blank of
0.5 m sodium hydroxide were carried through the entire procedure.
When dissdution was complete, a 0.3 rnl aliquot was removed and
placed into a tube containing 1.0 ml of 0.5
was ad d e d 5 m1 o f r ea g e n t

11

s~lution

sodium carbonate solution).

and 1.0 ml of 2.7

to 100 ml of 2 percent

After mixing, the tubas were

allow ed to stand at room temperature for 20 min.
0,5 ml of reagent

11

8 11 •

To this

A" ( p rep a r e d b '/ the ad d i t i on o f 1 • 0

ml of 1 percnet .cupric sulfate solution
percent potassium tartrate

m NaOH.

At this time,

(prepared by diluting commercial Folin-

phenol reagent solution

~ith

an equal volume of

was added to each sample and mixed.

dis~illed

water)

The samples were allowed

to stand at room temperature for 40 min to develop

color~

The absorbanca of the solution was determined at 500 nanometGrs
versus a reagent blank.

The concentration of protein was

determined by comparison of this absorbance with that of
standards.
10.

Deter mination

Ef

L-Tryptophan E_l'.rrolase

~tivity

L-tryptoph3n pyrrolas8 activity was estimated through
assay of kynurenine formed according to th2 methoj of · Knox
and Mehler (1950).
Incubations were carried out at 37°c for 60 min in media
containing 7.5 mmoles L-tryptophan, 2.0 ml of 0.1

m phosphate

buffer, pH 7.0, and 9,000 x g supernatant fraction containing
10-20 mg of protein in a total volume of 4.0 ml .

The reaction was stopped by the addition of 2.0 ml of
~5

percent rnetaphosphoric acid.

The flask contents were
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centrifuged, and a 3.0 ml aliquot was neutralized with 1.0 ml
of 1 N NaOH.
a blank.

The samples were read at 365 nanometers versus

The amount of kynurenine formed was calculated
3

from the molar extinction coeffecient of 4.53 x 10 •
11.

Det ermination of NADPH-Cytochrome c Reductase Activi_!:y

NADPH-cytochrome c reductase activity was determined
according to the procedure of Dahlner (1963), from the rate
of reduction of cytochrome c through assay of the optical
0

density of the reduced cytochrome at 550 nanometers at 30 C.
Three ml of reaction mixture contai ning 0.65 umoles NADPH
and 0.5

u~oles

cytochrome c in 0.33 mM KCN-phosph3te buffer

(0.5 M, pH 7.4) were placed in the reference and sample cuvattes~
The r eaction was started by adding 0.1 ml of microsomal
suspension containing 1-2 mg protein/ml to the sample cuvette.
The contents were mixed and recording was started immediately.
The reaction rate was linear for 3-5 mino
The amo'...lnt of cytochrorie reduced was calculated from the
molar extinction coefficient of 18.5 x 10
minus the oxidized
12.

cytoch~ome

3

for the reduced

c.

Determination of £Q.-Binding Pigmen.t (£:1.-450)

Concentration~

The determination of P-450 concentrations was based on the
recording of a differen:e spectrum generated by microsomes
treated with carbon monoxide as specifiad by Dahlner (1g63).
A reaction mixture of 6.D ml was prepared containing 1020 mg of microsomal protein and 0.05 m phosphate buffer, pH 7.4,
to which sodium

dit~ionite,

the microsomal pigments.

1 mg/ml, had

Three ml of the

bee~

add e d to reduce

reacti o ~

mixture was
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IV.
Physical Parameters

E..f.

RESULTS

Liver Enlargement

For characterizing the physical aspects of liver enlargement, rats were ~dministered pyrethrum, 200 mg/kg/day orally
for 23 days and sacrificed 24 hours subsequent to the last
administered dose.

The effects of pyrethrum on relative

liv er weights, water concentrations and total lipids are shown
in Table 1.
Relative liver weights of the pyrethrum treated animals
increased 23 percent as compared to controls, while body
weights and hepatic water concentratio,s were unaffected by
the tre atment .

Although the increase in total lipids is

statistically significant at the P: .05 level, it does not
account for the total increase in liver weight.
In Table 2 are shown the effects of pyrethrum administered
for 13 days at 200 mg/kg/day on relative liver weights,
protein and DnA concentrations.

Relative liver weights of t he

pyrethrum treated animals were increased 30 percent over that
of controls.

Although the body weight of the pyrethrum

treated animals was statistically greater at the P= .01 level,
it dosen't completely account for the increase in liver
weights, since the relative liver weights were significantly
great er .

Protein concentrations of whole liver homogenates,

9,000 x g supernatants anj 10 5 ,000 x g pellets were not
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TABLE 1.

Effect of pyrethrum, 200 mg/kg/day orally for 23
days 1 on liver to body weight ratio, total lipid
and water content

Mean ±.SE (N)
Control
Body l>Jeight ( g)

Treated

325.0 ±. 10.0 (6)

316. 0 ±.

s.o

(6)

-

Liv er l>Jei.ght ( g)
Body Weight (kg)

42.2 ±.

0.5 (6)

52.1 ± 1.8** (6)

Percent Water

63,9 ±.

0,4 (6)

62.7

Total Lipids
rr:g/g liver

44.6 ±.

1 • 1 (6)

49.7 .:±. 1.6*

;±.

*Pl:0.05 1 **Pf0401 as compared to control values,

0.9

( 6)
(6)

---

TABLE 2.

Effect of pyr e thrum, 200 mg/kg/day orally for 13 days,_ on liver to body
weight ratio, protein and DNA

!Ylean ± SE (N)
Treated

Control

**

147.0

± 2.o.9

( 8)

163.7

Liver Weight (g)
Body Weight (kg)

46 .• _o

;±. 0. 9

( 8)

59.8

±. 1.3 ** (6)

Protein (mg/g liver)
whole homogenate

99.8

±. 3.3

( 7) .

99.7

±. 1.5

( 6)

70.5

-

1. 6

( 7)

71.-1

.±. 2 •.4

( 6)

18.9

:±.. 0.7

(6)

19 0 7

±. 0.7

(6)

Body Weight (g)

9~000

x g supernatant

105,000 x g pellet

DNA (OD

600

**P~0.01,

/g liver)

.+

'

1 • 8 2 :±.. 0 ... 1 5 (.7 )

±. 2.9

(6)

1.30 .±. 0~02** (6)

as compared to control values.
tN

......
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significantly different from controls.

DNA concentrations

d3creased by 29 percent, suggestive of hypertrophy.

While

a combination of hypertro?hY and hyperplasiacould have
yielded the same results, microscopic examination of liver
sections showed a predo minance of hypertrophy.
Barbiturate Narcosis
In order to determine the effects of pyrethrum on hexobarbital and barbital induced narcosis, rats were administ ere d
pyrethrum, 200 mg/kg/day or an equal volume of corn oil,
orally for 6 days.

On day 7, approximat e ly half of each

group were administered hexobarbital, 135 mg/kg intraperitoneally, while the other half of each group was given
barbital, 200 ~g/kg intraperitoneally.

The duration of

narcosis was recorded, as well as onset in the case of barbital.
Table 3 sh ows the results of this study.
The duration of hexobarbital narcosis was decreased by
approximately 50 percent in the pyrethrum treated animals
while the onset and duration of barbital narcosis was unaffected.
In earlier studies (Table 4) pyrethrum administerad in
isoparaffinic oil verses a corn oil treated group, caused a
similar decrease in the duration of hexobarbital narcosis.
Hexobarbital serum levels at return of righting reflex were
measured and were not sign±ficantly different (P=0.05)
from control lev e ls.
In Vitro Metabolic Studies
The 9,000 x g supernatant fr act ions of liver ho mogenates
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TABLE 3.

Effect . of pyrethrum, 200 mg/kg/day orally for 6
days, on hexobarbital and barbital induced narcosis

Narcosis
Min+ SE (N)

--

Control

Hexo barbitaJ.
135 mg/kg

4008 ±. 1.7 (6)

Barbital
200 mg/kg
onset

121.-5 ±. 5.4 (10)
48.7 ±. 2.6 (10)

**P:OaD1, as comp a redto control values.

Treated

22.7 ±. 1.1**
128 •. 1 .±. 5.3
43.5 .±. 1, _4

(7)
( 11 )

( 11 )
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T/l.BLE 4.

1

Effect. of pyrethrum , 200 mg/kg/day orally for 12
2
days, on hexobarbital induced narcosis and hexobarbital serum levels at return of righting reflex

IYlean ±. SE (N)
Control
Treated
Narcosis (min)

58.6 ± 4o7 (6)

26.3 ±. 2.5** (6)

Serum Levels (ug/ml)

72.3 .±. 5.5 (6)

66.7 ±. 4 .. 7

(6)

1 Pyrethrum administered as 20 percent solution of pyr e thrins
in isop a raf f inic oil. Controls received an equal volume
of corn oil.
2 Hexobarbital, 150 mg/kg intraperitone a lly.
**P60~D1,

as compared to control values.
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prepared from animals used in the determination of para me ters
of liv er enlargement were employed in preliminary studies of
microsomal drug metabolism.

Rats that had been treated with

pyr ethrum , 200 mg/kg/day for 23 days were examined for changes
in in vitro

a~inopyrine

oxid ation (Tabl e.

5).,

demethylation and hexobarbital

Protein concentrations of the 9,000 x g

supern atants were not significantly (P=0.0 5 ) altered by the
pyrethrum treatment.

Hexobarbital oxidation was increased

to 268 percent of control levels in the pyrethru m treated
group.

However, the N-demethylation of aminopyrins was not

significantly altered.
Further investigation of the in vitro metabolism of
aminopyrin e showed the production of formaldehyde by this
fractio n was not linear for 60 min (Fig ure 1).

However,

when portions of the above prepar ed samples were combined and
assayed in duplicate determir1ations for the production of
formaldehyde at 10, 20, and 30 Tiin there were no

significan~

differences between pyrethrum treated and control animals.
The production of formaldehyd9 was found to be linear for at
least 30 min.
In a prior study of in vitro metabolism, rats that were
admini stered pyrethrum in isoparaffinic oil, 200 mg/kg/day
for 12 days, showed no aiteration in the N-demethylation of
p-chloro-N-methylaniline (Table 6).

However, these same

animals showed a decrease in hexob a rbital induced narcosis
(Tabl e 4).
The investigation for alterations in in vitro drug
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TABLE 5.

Effect of pyr eLhrum , 200 mg/kg/day orally for 23
days, on aminopyrine demethylation and hexobarbital
oxidat ion by 9,000 x g supernatants

Mean .±. SE (N)
Control

Treat ed

Protein, mg/g liver

75.1

1.9 (6)

74.2 .±. 1.4

( 6)

Aminopy rine
HCHO formed
nm ole s/mg protein/50 min

44.8 .±. B.1 (6)

52.6 .±. 4.2

( 6)

Hexobar bital
nmoles/mg protein/30 min

30.3 ±. 6.9 (6)

81o2 .±. 3.01<-* ( 6)

;±.

*"*·P:O. 01, as co.1 1pared to control values.

~ g'.10r

- - - -8

l-

ex:
:z

0::

w

C'-

3 ., 0

::::>

en
E

ex:

0::
Ll

............
0

w 2. 0
E

0::

0
Li..

0

Q CONTROL
LJi. TREATED

:r:
LJ

1•0
U1

w

_J

0

E

I

::::>

10

20

30

40

50

60

TIME (min)
FIGURE 1. Effect of pyrethrum~ 200 mg/kg/day orally for 23
days, on aminopyrine demethylation by 9,000 x g supernatants .
Each ~oint represents mean of paired samples assayed in duplicate .

(.,J

--J

38

TABLE 6.

1

Effect of pyrethrum , 200 mg/kg/day orally for 12
days, on p-chloro-N-methylaniline demethy lation and
aminopyrine de methy lation by 9,000 x g supernatants

!Ylean + SE (N)
~----~
Control
Tre a t ed

~~--~~-

---~·--------

p-Chloro- N-meth ylaniline
p-chlo roa niline formed
nmoles/mg protein/30 min
Aminopyrin e
HCHO formed
nmol es /mg protein/60 min
1

50.8

45.9 ;±. 5-.9 (6)

;!:.

5o2 (8)

59.9 ±. 6.9 (6)

Pyrsthrum administered as 20 perc en t solution of pyr eth rins
in isoparaffinic oil. Controls received an equal vol ume
of corn oil.
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metabolism was continued with examin3tion of EPN detoxification,
and p-nitroanisol 0-demethylation.

In Table 7, rats that had

been treated with pyrethrum, 200 mg/ kg/day orally for 13 days,
showed significant increases in the detoxification of EPN,
and demethylation of p-nitroanisol, 148 and 176 percent of
co n trol levels, respectively.

Hexobarbital oxidation was

increa sed to 173 percent of control le vels.
The in vitro metabolism of EPN and p-nitroanisole by
9,000 x g supernatants were chosen as indicators of microsomal

drug metabolism in studies d3signad to establish a dose-effect
relations hip as well as the time course and reversibility of
the pyrethrum caused liver changes.
In a dose-effect study, groups of 4 rats were administered
pyreth rum , 85,200 or 500 mg/kg/day for 15 days.
gro~p

of animals was administ8red corn oil.

graphically relat es the

informatio~

An additional

Figure 2

from the tables and shows

the results of this study.
As shown in Table 8, in comparison to control levals,
administration of 85 mg/kg of pyrethrum caused no significant
liver enlargement, while 200 and 500 mg/kg caused 24 and 37
perc ent increases.

Protein concentrations of whole liver

homog enates , 9,000 x g supernatants, and 105,000 x g pellets
were not significan tly different from controls at all dosages
(Tabl e 9).

As se e n in Table 10, the metabolism of EPN and

p-nitroani sole was significantly incre ase d at the 3 doses
used in the pyrethrum treated animals.

With increasing

dosag e , the metabolism of EPN was increas ed to 124, 140 or

40

TABLE 7.

Effect of pyrethrum, 200 mg/kg/day orally for 13 days,
on EPN detoxification, p-nitroanisole demethylation
and hexobarbital oxidation by 9,000 x g supernatants

IYlean ±. SE ( N)
Treated

Control
EPN
p-nitroph encl formed
nmoles/mg protein/60 min

13.4 ±. 1o4 ( 4)

19.B ±. 1.4** ( 5)

p-Nitroanisole
p-nitrophenol formed
nm oles mg protein/60 min

16 .. 5 ±. 1 .. 3 (4)

29.0

Hexobarbital
nmole s /m g protein/30 min

27.6 ±. 2.0 ( 7)

4 7.• .7. ± 2. 9.*-l<- -( 6)

**Pf0.01, as compared to control values.

;:!:.

2. 2*-l<· (5)
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TABLE 8.

Effect of pyrethrum, three dose levels orally for 15
days, on body weight and liver to body weight ratio
----~

Dose
(mg/kg)

Mean ±. SE (N)
Body Weight (g)
Liver7Body (g/kg)

Control

315 .. 0 ± 24.0 (3)

43.8 ±. 1.8

(3)

318.5 ±. 22.1 ( 4)

tf4. 1 ±. 0.9

(4)

200

299.8 ±.

51.6 ±. 1.9*

(4)

500

301.0 .:±. 10.7 (4)

85

*P~0.05,

**P~0.01

8.8 (4)

59.1 ±. 2.4* * (4)

as compared to control values.
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TABLE 9.

Effect of pyrethrum, three do s e levels orally for
15 days, on liver protein concentrations

Fraction

Dose
(mg/kg)

Whole Homogenate

Control

9,000 x g Supernatant

105,00 0 x g Pellet

Protein
mg/g liver ±. SE (N)
110.4

5.3

(3)

85

119.6 ±. 1.8

( 4)

200

115.6 ±. 1.9

(4)

500

123.5 ±. 2.0

( 4)

70.2 ..±.. D.6

( 3)

85

72.6 ±. 2.8

(4)

200

70.0 ±. 1.5

( 4)

500

75.3 ±. 1.1** ( 4)

Control

Control

;:!:_

15.5 ±. D.7

(3)

85

14.0 ±. 0.3

( 4)

200

13.8 ..±.. 0.9

( 4)

500

15.5 ±. 006

(4)

**P::D.01 as compared to control values.
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TABLE 10.

tffect of pyrethrum, three dose levels orally for
15 days, on the detoxification of EPN and demethylation of p-nitro a nisole by 9 1 000 x g supernatants

p-nitrophenol for me d
nmoles/mg protein/60 min .±. SE (N)

Dose
(mg/kg)

p.-N i tr o an is o l e

EPN

--

---- -- -

Control

9.2 ± 0.4

( 3)

7.5 ±. 0.5

( 3)

200

11.4 ± 0,8* ( 4)
12.9 ±:. Oc4** (4)

10.1 ±. 0.6* (4)
13. g ±. 1.2** ( 4)

500

16., 0 ±. 1.2** (4)

15.9 ±. 1.3** (4)

85

*Pf0.05,

·**P~O.

01 as compared to control values.
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174 percent of controls while the metabolism of p-nitroanisole was increased to 136 7 187 or 21j perc ent of controls.
Figure 2

sho~s

that with increasing dosage, these parameters

increased in an app rox imately logarithmic fashion.
In order to examine the time cours e and reversibility
of these changes, groups of 4 rats were administered. pyrethrum,
500 mg/kg/day f.or 4, 7 and 17 days and sacrificed 24 hours
subsequent to the last administered dose.

An additional

group was treated for 17 days and sacrificed on the 24th da y.
Tables 11 to 13 and Figure 3 show the

~esults

of this study

As seen in Table 11, with increasing duration of treatment,
relative liver weights of the pyrethrum treat ed ani mals were
increased

~o

148, 15e or 160 percent of control levels after

4, 7 or 17 days of treatment, respectively.

However, within

7 days following cessatio n of the 17 day treatment, the
relative li0er weights of these animals returned t o control
levels.
The --in vitro metabolism of Epn and p-nitroanisole was
- ~~

significantly increased in these animals as compared to
controls.

As illustrated in Table 12 and 13, the greatest

increases in enzyme activity occurred within the first four
days of treatment.

EPN metabolism was maximum on the 8th day,

where it was 185 percent of control, and had decreased somewhat by the 17th day to 169 percent of control.

Return to

control levels occurred within 7 days of cessation of tre at ment.

p-Nitroanisole metabolism increased

co nti n~ally

throughout the period of treat ment (Table 13), and did not
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TABLE 11.

Effect of pyrethru m, 500 mg/kg/day orally, on
liver we ight to body we ight ratio

Days of
Treatment

Day of
Sacrifice

L~

5

51,.4 ±. 1.4 (4)

7

8

46.9 .±. 0.6 (4)

75 .. 9 ±. 0.3* * ( 4 )
74.0 ±. 1. o -x- -J<- (4)

17

18

47.2 .±. 0.8 ('4)

75.4 .±. 1.9** (4)

17

24

40.5 ± 2,. 0 ( 8)

38.0 ± 0.8

--

Liver/Body (g/kg) ±. SE (N)
Treated
Control

-r•*P:f0 9 01, as compared to control values,.

( 3)
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TABLE 12.

Effect of pyr ethrum, 500 mg/kg/d a y orally, on the
detoxific at ion of EPN by 9 1 000 x g supernatants

Days of
Treatment

Day of
Sacrifice

p-nitrophenol formed
nmoles/m g protei n/60 min
IYI ean

-1·

SE (N)

Control
4

5

8.9 ±. 0.2 ( 4)

15. 2 ±. 1,,2** (4)

7

8

11.8 ±. 0,.5 (4)

21 .o-9 ;±. 0.9** (4)

17

18

9.8 .±. 0.2 (4)

t.,6 7 ±. 1...,0*-li- (4)

17

24

11.8 ±. 0.8 ( 4)

**P!:0.01, as compared to control values.

f~ ·:\ ...

Treated

0

1.1... 5 ±. 0_..4

(4)
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TABLE

13~

Effect of pyrethrum, 500 mg/kg/day orally, on dsmethylation of p-nitroanisole by 9,000 x g supernatants

Days of
Treatment

~ay of
Sacrifice

p-r.itrophenol formed
nmoles/mg profein/60 min
Mean .±. SE (N)
Control
Treated

o. 4. ( 4)

4

5

13~4

±.

7

8

18.9

j-_ 0~9

17
17

20.1

;!.

0.7** (4)

( 4)

30.2 ±. 3.1** (4)

18

1 2. 4. .±. 0.7 (4)

22.2 ±. 0.7** ( 4)

24

13.7 ±. 1 ...0 (4)

14.6 ± 1.2

-K-*P:Oo 01, as compared to control values.

( 4)
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appear to reach maximum levels on the 17th day where it was
179 percent of controls.

Return to control levels occurred

within 7 days of cess atio n of treatmgnt.
In order to

deter~ine

if these changes were part of a

generalized increase in cellular metabolism or were more
specific, the in vitro oxidation of tryptophan was examined
(Table 14).

The tryptophan pyrrolase activities of 9,000 x g

supgrnatants from livers of the 7 and 17 day treated animals
were assayed and found to be not significantly different from
controls (P =0.05).
Components

.9.f.

microsomal Electron Transport System

In order to account for the increa se in microsomal
drug metabolizing activity, components of the microsomal
electron transport system were examined for possible incre ase
in activity.

Significant increases were found in the NADPH

dependant cytochrome c reductase activity of microsomes from
livers of animals employed in the time-effect study (Table 15
and Figur8

3).

With increasing

d~ration

of treatment, this

activity was increased by 38, 54 and 27 percent on day 5 1 7
and 17, respectively, but returned to control levels within
7 days aft er cessation of treatment.
Cytochrome P-450 levels of pyrethrum and corn oil treated
animals were examined.

Rats were treated with pyrethrum, 500

mg/kg/day or corn oil for 4 days (Table 16).

As correlates,

liver to body weight ratios and microsomal drug metabolizing
activities were measured.

In co mpa ri son to controls, relative

liver w3ights were increased to 141 percent while the in vitro
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TABLE 14.

Effect of pyrethrum, 500 mg/kg/day orally, on the
oxidation of L-tryptophan by 9,000 x g supernatants

Days of
TreatmEnt

kynurenine formed
nmoles/mg protein/60 min
!YI ean ±.

Control

SE (N)
. Treated

7

22.3 ±. 3 .. 4 ( 4)

21~5

17

34,.1 ± 1. 7 (4)

33.7 ±. 1 0 1 (4)

±. 1.4 (4)
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TABLE 15 .

Effect of pyrethrum, 500 mg/kg/day orally on NADPH cytochr ome c reductase activity in liv er microsomes

Day s of
Tre atmen t

Da y of
Sacrifice

nm oles/mg protei.n/min
Mean ±. SE ( N)
Control
Treated

4

5

88.4 ±. 6.2 ( 4)

120.8 ±.

6.8** (4)

7

8

72.3 ±. 4. 1 ( 4)

112.6 ±

5. 2*.;(• ( 4)

17

18

190.9 ±. 4.8 ( 4 )

17

24

7 Lf • 7 ±. 3.2 ( 3 )

**P~D.01

as comp ared to cont ro l values .

241.8 ±. 11. 8** (4)
74.7

;,!-_

5.8

(4)
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TABLE 16.

Effect of pyrethrum, 5PO mg/kg/day orally for 4 days, on components of
the NADPH-linked electron transport system in liver microsomes and EPN
detoxification and p-nitroanisole demethylation by 9 1 000 x g supernatants

IYlean ±. SE (N)
Tre ated

Control
EPN
p-nitrophenol formed
nrnolss/rng protein/60 min

7.5 ±.

p-Nitroanisole
p-nitrophenol formed
nmoles/mg protein/60 min

12.1

NADPH-Cytochrome c Reductase
nmoles/mg protein/min
Cytochrome P-450
~
E( 450 _ 500 )/mg protein x 1n- .

;±.

0~3

(4)

13. 5 ±.

0 .. 8*-1<· ( 4)

0.6 (4)

18.4 .±.

0.8** (4)

189.0 ±. 15.3 (4)
..

33.8 ±.

2. q (.4)

372.2 ±. 19.4** (4)
51.0 ±.

3.,.8** (4)

**Pf0.01, as compared to control values.
Ul
(.,J
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metabolism of EPN and p-nitroanisole by 9,000 x g supernatants
was increased to 181 and 14J percent, respectively.

NADPH

dependant cytochrom e c reductase levels were incre a sed to 197
percent of control while cytochrome P-450 lev e ls we re increased
to 141 percent of controls.
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V.

DISCU SSION

Liver enlargem e nt due to chronic administration of drugs
with var ying ch emi cal and biological characteri s tics i s of
interest not only for toxicologic a l studies but also for
studies of the regul at ion of all growth and cell

divi sion~

In th e absence of irr evers i ble pathological damage , the toxicological significance of this

pheno m~non

cannot be assessed

until more is known of the essential natur e of the enlargement,
as well as the ini t ial r e actions, mechanisms, and the effect
the drug has on liver met a bo lis m.
Analyses were

carri e~

out to determine if the pyrethrum

induced liver weight increases were due to fat deposition ,
edema, proliferation of specific subcellul ar particl es , a
coordinated growth of the whole cell (true hypertrophy) or
an incre ase in the num ber of cells (hyperplasia).
Control animals received a volume . of corn oil vehicle
equal to the total volume of

pyr~thrum

solution administered

in ord e r to avoid liver weight or body we ight ch anges due to
differences in diet.
Measurem en t of water and lipid concentrati ons (Ta ble 1)
sho wed that th e liver weight incr eases we re nffit due to fat
deposition er edema .

If

ed e~a

or f a t deposjtion was the

principal c ause of th e en l argement , measurement of protein
co ncen tr at ion of wh ole liv er homogenates and su b-fractions
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should have indicated this through dilution of protein per
unit liver.
(Table

2),

No dilution of protein concentration was observed
while measurement of lipid and water concentrations

provided direct confirmation of the lack of edema or fat deposition.
Liver fractionation provided information
physiological aspects of the enlargement.

~n

the cell-

The 9,000 x g

supernatant fr act ion contains mainly microsomes and cell sap
since whole cells, debri s , mitochondria and nuclei are removed
by sedimentation at this centrifugal force.
isolated by sedimentation at 10 5 ,000 x g.

Microsomes wEre
Lack of alterations

in protein concentrations of thes e fractions indicated that
the liver weight incre ases were not due to proliferation of
microsomes.
The question of whether hypertrophy or hyperplasia
caused the increase in liver
measurement of

D~A

of liver sections.

~eights

w2s examined through

conce ntrations and microscopic examination
Increases in liver weight combined with

decre2ses in liver DNA concentrations are indicative of cellular
hypertrophy.

Increases in liver DNA concentrations are sug-

gestive of hyperplasia with a predominance of imm a ture cells.
As seen in Table 2, DNA levels were found to be decreased by
approximately 30 percent on a per gram of liver basis as compared to a 30 percent rise in total weight.
of hyp ertr ophy, a

~ixture

Altough suggestive

of hyp er plas ia with immature cells

and hypertrophy might have yi elded the same percentage ch anges .
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Examination of liver sections showed a predominance of enlarged
cells with a slight incr eas e in mitotic divisions and smaller,
immature cell s .

These studies suggested tha t . the _iver weight ·

increases resulted primarily from a coordJnated growth of the
whole cell.
While the chemical constituents of the livers of treated
animal s and of cont rols were similar, one could not necessarily
conclude that normal and pyrethrum induced liver gro wth is
identic al.

Whole tissue is employed in ch emical determinations

of various cell constituents, such as lipid and protein, and
does not t a ke into consideration functional variation of subcellular components.

With normal

~iver

growth, the inc rease

in total protein should show a proportionally con stant rise
in all liv er erzymes.
panying

pyrethr~m

The increa se in total protein accom-

induced liver

a more detailed etudy.

enlar~ement

was subjected to

Possible alterations in microeo ma l

drug metabolism were first examined in vivo followed by examinati on of microso mal and cytopl asm ic enzymes in vitro.
Duration of hexo ba rbital narcosis, which is limited by
its metabolism in hepatic microsomes (Cooper and Brodie , 1955)
was decreased in pyrethrum treated animals (Table 3). · The
onset and duration of narcosis due to barbital, which is
ex creted unmetabolized (Dorfman and Goldbaum, 1947;
and Van Dyke, 1958: Ebert .§l
pyrethrum

pretre a t~ent.

~'

Mayn~rt

1964), was unaffe cted by

These da ta suggested that th

0

decreases

in hexobarbital narcosis resulted from an increas e in micro somal drug metabolism r at her than alterations in central

58

nervo us system sensitivit yo

This idea was further sub sta n-

tiated by the l ack of differences in hexobarbital serum levels
at return of ri ghting r eflex in the two groups (T ab le 4).
The study was c ont in ued wit h an examination of in vitro
mic r os oma l drug metabolism in order to determine if the
decrea ses in

he~ obarb ital

narc osis resulted only from an

incre ased metabolic cap 2cit y of a larger liv er or wa s co mb ined
with incre ases in spec i fic enzymatic activity.

Measurement

of aminopyrin e N-demethylase activity was chosen as a possible
indic ator of altered wicrosomal drug metabolism since its
meta bolism is increas ed by two prototypes of inducing agents ,
3-w.ethylch olanthr ene end

phenob arb ital~

The N-demethylation

of aminopyr ine was found to be unaltered by pyrethrum treatment (Table 5) .

The N-demethylation of p-chloro-N-methyl-

aniline was also found to be unaltered by pyrethrum treatment (Table 6) .
Since the decrease in hexobarbital narcosis

~ithout

a

conco mitant alteration in barbital narcosis sugges te d an
increase in microsomal drug metabolism, even though there
were no incre a ses in the N-demethylation of

p-chlorom~thyl

aniline or aminopyrine, the in vitro metabolism of hexobarbital
was examined.

Tables 5 and 7 sho w that in vitro hexobarbital

oxidas e activity was elevated by pyrethrum treatment.
In his revi e w, Conney (1967) drew a di st inction between
the selective ind u ction effects of the poly cyclic hydrocarbons,
which ind uce only a few activities such as zoxazolamine
hydroxyl ase and azo dye demethylase bu t not hexobarbital oxid Gse
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or aminopyrine demethylase, and the generalized inductive
effect of ph e nob arbita l which induces all fo ur a ctivities.
Becau se of the se otservations, the lack of incr ease in aminopyrine dem et hyl ase

WES

subjected to a more detailed study.

Samples that showed no incr ease in aminopyrine demethylase
activity when assayed for formaldehyde production at 60 min
were pooled in pairs and in duplicate determin at ions, assayed
for formaldehyde production at 10, 20 and 30 min.

As shewn

in Figure 3, there was no significant difference between
pyr ethrum treat e d and control animals in the prodcction of
formald eh yd e at 10, 20 and 30 min , although the rate was
approximately line ar for only 30 min.
This work

confir~ed

that of Soyka (1969), who noted that

even if linearity for 15 min was accom plished, the use of too
small a qcantity of glucose-6-phosph ate limited the production
of formaldehyde.

Thus the activity of adult liver erroneously

appeared to be less than that from 20 day old animals if
studied after 30 min of incubation.
The increase in hExobarbital oxidase activity withoct
an increase in aminopyrine demethylase activity suggested
that pyrethrum did not resemble in effects produced either
prototype of enzyme induc er .

It is interestirig to note that

in studying th e structure activity relationships of substituted
phenols on liver we ights and liver enzymes in the rat, Gilbert
~ ~

(1969) found there was no dirEct relationship between

liver weight increases and incr eases in hexobarbital oxidase
and aminopyrine demethyl ase acti viti es ,

Cert a in co mpc unds
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consi stently showed a greater effect on aminopyrine demethylase
than on hexobarbital oxidase while the reverse also occurred.
Th ey further found that 2,6-di-tert-butyl-4-hydroxymethylphenol induced hexobarbital oxidase strongly with no corresponding increase in the activity of aminopyrine demethylase .
This new

catego~y

appears td exemplify the effects of pyrethrum.

In order to further categorize the effects of pyrethrum,
other microsomal enzymes were examined for alteration in
activity, including p-nitroanisole 0-demethylase and EPN detoxification.

Table 7 shows that the activities of both of these

enzyme s were increasedo
At this point it was of interest to determine if these
incr eases in drug metabolizing activity were part of a generalized increase in cellular metabolic activity or were mere
specific as suggested by the lack of increase in aminopyrine
N-demethylase and p-chloromethylaniline N-demethylase activitieso

Lack of increase in tryptophan pyrrolase activity

(Table 14), an enzyme localized in the 105,000 x g supernatant
fraction and therefore a probable cytoplasmic enzyme, further
supported the hypothesis that the enzymatic increases were
specific in nature, indicative of true enzyme induction.
Investig ation of liver enlargement and increases in drug
metabolizing activities due to pyrethrum was continued with
establishment of a dose-effect relationship (Figure 2).

The

results of this study indicated that increases in enzyme
activity ware evident before liver enlargement.
enzyme activity paralleled the liver enlargement .

Increases in
These
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parameters increased in a logarithmic fashion with increasing
dos ages indic at ing a dose-effect rel at io nship .
sug~ested

Th e data also

that tha maximum re sp ons e of the parameters had not

been re ached , although higher dos es are within th a lethal
range of pyrethru m.
An investiga tion was also undertaken to
course a nd reversibility of these changes

s~udy

(Fig~re

the time
3).

Liver

enlarge men t and p-nitroanisole metabolism increased with
increasing duration of treat men t.

The greatest increase

occurred during the first four days of treatment, with smaller
increases at the next consecutive measurements, suggesting the
attainment of a platea u of peak activity after
of treatment.

ab~ut

2 weeks

EPN de toxification and NADPH-cytochrome c

reductase activity paralleled each other in activity.

The

greatest increas e in activity occurred during th e first four
days,

b~t

unlike the time course of p-nitroanisole

and liver enlarg ement , it was maximum on the
declined

so~ewhat

and Gilbert

et~

by the 18th day.

~etabolism

8th day and had

Martin and Gilbert (1968)

(1969) recog ,1 ized that continued administra-

tion of a compounj could lead to regression of the initial
effect .

These studies suggest that increasas in liver size

cannot necessarily be equated with increases in enzymatic
activity .
All parameters measured, returned to control levels within
7 days after ces sat ion of treatment showing that the changes
are spontaneously reversible upon discontinuation of exposure
to pyrethrum.
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True enzyme inducers, stimulants of hepatic microsomal
drug metabolism, have the abilit y to increase components of
the microsomal electron transport system.
pheno barbital and

3-~ethylcholanthrene

For example,

cause increases in

P-450 conc e ntrations, and phenobarbital increases th 3 activity
of NADPH-cytochrome c reductase (Conney, 1967).

These obser-

vatio ns suggested that pyrethrum may have a similar inductive
effect on these components of the microsomal

electro~

port, and consequently be a true enzyme inducer.

trans-

As shown

in Tables 15 and 16 and Figure 3 , both of these components
are elevated by pyrethrum treatment .
It sh ou ld be noted that the magnitude of the doses
employed in this study would not be encountered in normal
usage of pyrethrum.

However, this study does not indicate

a no-effect level for py:ethrum.
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VI.
1,

SUMMARY AND CONCLUSIONS

Liver enlargement due to pyrethrum is associated with
proportional increases in total water and total protein
of whole liJer, 9,000 x g supernatant fraction and 105,000
x g pellets.

St atistically significant (Pf0.0 5 ) increases

in total lipid .per gram of liver did not account for th3
total incr ease in liver weight.

The en lar gement was

further associated with a decrease in DNA per gram of
/

liver, suggestive of hypertrophy.

Microscopic examination

of liver sections supported this hypothesis.
2.

Liver enlargement due to pyrethrum is associated with a
decrease in hexobarbital induced narcosis.

Hexobarbital

serum levels at awakening were not significantly different
in control and pyrethrum treated animals .
duration

or

The onset and

barbital narcosis was not significantly al t ered

by the pyrethrum pretreatmento

These results suggested

that the decrease in hexabarbital induced narcosis was due
to increas ed microsomal metabolism of the drug rather than
a ch ange in CNS sensitivity to the drugo
3.

In vitro increases in specific microsomal oxidation of
hexobarbital, 0-demethylation of p-nitroanisole and detoxification of EPN were associated with
Th e observed lack

or

~he

liver enlargement.

increase in specific activity of

aminopyrine demethylase did not result from the duration
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of incubation employed in the assa y, although the pro duction of form a ldehyd e was not linear for 60 min jut
lin ear for at l east 30 min.
4.

]..!2 vit ro tryptophan pyrrolase activity , a 105,000 x g

sup ernatant enzyme , was not significantly altered by
pyr ethrum

t~eatment.

The lack

or

i ncrease in this enzyme ,

as well as th e l ack of increases in aminopyrine N-d eme thylase
and p-chlorornethylaniline N-demethylase, suggested that
the inc reases in microsomal drug metabolism were not part
of a generalized increase in c e ll u lar metabolism .
5.

Incr eases in liver to body weight ratios and incre a3e s in
met abolism of p-nitroanisole and of EPN by 9,000 x g supernatants were found to be dose rel ated .

At the lo wast dose

us ed of 85 mg /kg, inc reases in microsomal drug metabolism
wer e evident before liver enlarge ment .

Peak c c tivity of

th ese parameters was not apparently r eached at the highest
dose used of 500 mg/kg, although higher doses were within
the leth a l range of pyrethrum.
6.

Incr eases i n liv ar to body weight ratios and incre a ses in
metabol ism of p-nitroanisole and of EPN by 9,000 x g s uper natant s were found to be time rel ated .

The

g~eatest

incre ases in the3e p arameter s occurred within the first
four days of treatment, but did not appear to re a ch plateau
l evels simultaneously.

The incre ase in NADPH-cytochrome c

r eductase , a component of the microsomal electron transport system , was also time rel ated .

It is import ant to

no te th a t all parameters measured return ed to control
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levels within 7 days after cessation of treatment,
suggesting that irreversible changes had not occurred.
7.

Increases in P-450, a component of the microsomal electron
transport system, were associated with increases in liver

to body weight ratios and increases in EPN detoxification,
p-nitroanisqle demethylase and NADPH-cytochrome c reductase.
8.

These findings are consistent with and support the hypothesis that pyrethrum caused liver enlargement results from
true hypertrophy.

It is proposed that increases in specific

microsomal drug metabolizing activity , as well as an
incre ase

in metabolic capacity resulting from the larger

liver, account for the decrease in hexobarbital induced
narcosis.

It is proposed that the increases in specific

enzyme activity result from the synthesis of new protein
and that in fact, pyrethrum is a true enzyme inducer.
These data suggest the need for further investigation to
reevaluate the use of pyrethrum as a non-inducing insecticide.
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